The number of people with susceptibility test result for rifampicin in Finland
Finland: The number of people with susceptibility test result for rifampicin was 86.14 in 2021. ▼ Falling
Latest (2021)
86.14
Change on year
down 10.4%
World rank
83rd
of 146 countries
All-time high
96.4
in 2017
All-time low
86.14
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Finland, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Finland stood at 86.14. That is the lowest value across all 5 years on record.
The figure is down 10.4% on the previous year and down 10.6% over five years.
That places Finland 83rd out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Finland, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 96.4 | — |
| 2018 | 91.37 | -5.2% |
| 2019 | 91.67 | +0.3% |
| 2020 | 96.15 | +4.9% |
| 2021 | 86.14 | -10.4% |
Finland compared with similar countries
- Finland's 86.14 is below the median for high income countries, which is 92.6, 93% of the median. (56 countries reporting)
- Finland's 86.14 is below the median for Europe & Central Asia, which is 93.52, 92% of the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 93.15 | 91.37 | 96.4 | 3 |
| 2020s | 91.15 | 86.14 | 96.15 | 2 |
Countries ranked near Finland
More health data for Finland
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4544 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,271 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4631 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.1502 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Finland?
- The number of people with susceptibility test result for rifampicin in Finland was 86.14 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Finland?
- The highest recorded value was 96.4 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Finland?
- The lowest recorded value was 86.14 in 2021.
- How does Finland rank for the number of people with susceptibility test result for rifampicin?
- Finland ranks 83rd out of 146 countries with data for 2021.
- Where does this Finland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).